No Data
No Data
Cantor Fitzgerald Maintains Tourmaline Bio(TRML.US) With Buy Rating
Chardan Capital Initiates Tourmaline Bio(TRML.US) With Buy Rating, Announces Target Price $70
Tourmaline Bio Initiated at Buy by Chardan Capital
Tourmaline Bio Price Target Announced at $70.00/Share by Chardan Capital
Jefferies Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $64
Companies Like Tourmaline Bio (NASDAQ:TRML) Are In A Position To Invest In Growth